As Rivals Stand Silent, One Health Insurer Protests G.O.P. Plan
Dr. J. Mario Molina, one of the few insurance executives to criticize the House bill publicly, says it could harm insurers and patients alike.
Highlights
-
Photo
CreditJustin T. Gellerson for The New York Times -
Photo 
CreditTim Shenk/Doctors Without Borders New Vaccine Could Slow Disease That Kills 600 Children a Day
A lower-cost vaccine provides strong protection against rotavirus, a diarrheal disease, and could be particularly useful in poorer countries, researchers said.
-
-
Photo 
CreditGetty Images Phys Ed
Should 15,000 Steps a Day Be Our New Exercise Target?
A new study of postal workers in Scotland suggests we should aim for far more than the 10,000 daily steps commonly recommended.
-
Photo 
CreditSouthern Illinois University/Science Source 9 Deaths Are Linked to Rare Cancer From Breast Implants
The problem is more likely to occur with textured implants than with smooth implants, the F.D.A. said, and it is usually treatable and not often fatal.
-
-
Photo 
CreditYana Paskova for The New York Times Popular Prostate Cancer Therapy Is Short, Intense and Unproven
Researchers hope a study will shed some light on a cancer treatment, using radiation, that is growing in popularity and surrounded by questions.
-
Photo 
Credit Sperm Counts via Your Cellphone
A $5 cellphone add-on provides a quick and easy measure of your sperm count and motility.
-
Public Health
Photo 
Credit Fewer Americans Would Be Insured With G.O.P. Plan Than With Simple Repeal
The Republicans’ repeal plan of Obamacare would actually result in one million more people being uninsured, according to the C.B.O.
-
Photo 
CreditSteven Senne/Associated Press Compounding Pharmacy Owner Not Guilty of Murder After 60 Meningitis Deaths
A jury convicted the owner of the New England Compounding Center, blamed for an outbreak that killed 60, of racketeering charges but acquitted him of murder.
-
Photo 
Credit Pop a Pill for Heartburn? Try Diet and Exercise Instead
Proton pump inhibitors are linked to problems like nutrient deficiencies, joint pain, bone fractures, heart attacks and dementia.
Cell Wars: The Science of Immunotherapy
More in Cell Wars: The Science of Immunotherapy »-
Photo 
CreditJoshua Bright for The New York Times How to Find Clinical Trials for Experimental Cancer Treatments
Most major cancer centers post the trials in which they participate on their websites. But other sites show more options.
-
Photo 
CreditAl Drago/The New York Times In Cancer Trials, Minorities Face Extra Hurdles
As immunotherapy research takes off, the patients getting the treatment have been overwhelmingly white. Researchers know this and say they are trying to correct it.
-
Public Labs, Corporate Gains
Photo 
CreditJesse Dittmar (left) and Emily Berl (right) for The New York Times Harnessing the U.S. Taxpayer to Fight Cancer and Make Profits
Public funding is backing a new immunotherapy treatment, but the bulk of any profits will go to a private company. So are taxpayers getting a good deal?
-
Photo 
CreditLeft: Lynn Donaldson for The New York Times Right: Laura McDermott for The New York Times Cancer-Free: One Recovery Inspires Another — and Could Help Thousands
The science reporter Denise Grady writes about the connection between two immunotherapy success stories.
-
Photo 
CreditLaura McDermott for The New York Times 1 Patient, 7 Tumors and 100 Billion Cells Equal 1 Striking Recovery
The recovery of a woman with advanced colon cancer, after treatment with cells from her own immune system, may help doctors develop new treatments for other patients.
